Violaceous Nodules on the Leg of an Alemtuzumab-Treated Kidney Transplant Recipient: Challenge

Le résumé fourni par la source

CLINICAL HISTORY A 43-year-old woman with end-stage renal disease secondary to autosomal dominant polycystic kidney disease, on peritoneal dialysis since 2020, underwent a deceased-donor kidney transplant in September 2024. Induction immunosuppression consisted of alemtuzumab, followed by maintenance tacrolimus, mycophenolate mofetil, and prednisolone. Early after transplantation, she developed a class I donor-specific anti-Human leukocyte antigens (HLA) antibody with a biopsy showing changes suspicious for antibody-mediated rejection and was treated with 7 sessions of plasma exchange and intravenous immunoglobulin in addition to high-dose corticosteroids and optimization of mycophenolate. Her medical history also included type 2 diabetes mellitus and hypertension. In January 2025, approximately 4 months after transplantation, she presented with a 4-week history of painful nodules on the medial aspect of the right lower leg. The lesions had progressively enlarged and coalesced into a violaceous, crusted plaque with focal ulceration (Fig. 1). She denied fevers, weight loss, or other systemic symptoms. Multiple courses of oral antibiotics prescribed in primary care for a presumed bacterial skin infection had not resulted in improvement. Examination revealed several firm, tender, violaceous nodules and an irregular ulcerated plaque on the medial lower leg; there was no palpable lymphadenopathy and no other cutaneous lesions.FIGURE 1.: Multiple tender, violaceous nodules coalescing into an ulcerated plaque on the medial lower leg of a kidney-transplant recipient.HISTOPATHOLOGIC FINDINGS A 4-mm punch biopsy from the edge of a nodule showed a lobulated endophytic squamoproliferative lesion with parakeratosis, neutrophilic microabscesses, and mild cytologic atypia, raising concern for keratoacanthoma or well-differentiated squamous cell carcinoma in the setting of recent renal transplantation. Because of the multifocal, tumor-like appearance, a larger incisional biopsy was performed to further characterize the process (Fig. 2).FIGURE 2.: Histopathology of the incisional biopsy. A, Low-power hematoxylin–eosin–stained section showing irregular pseudoepitheliomatous epidermal hyperplasia with broad lobulated squamous downgrowths overlying a dense nodular dermal inflammatory infiltrate. B, Medium-power view highlighting tongues of bland squamous epithelium extending into the dermis, surrounded by a mixed inflammatory infiltrate. C, High-power view showing neutrophil-rich microabscesses and “dirty” necrotic debris between collagen bundles adjacent to reactive squamous epithelium with only mild atypia.WHAT IS YOUR DIAGNOSIS? (Continued on page 250)

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.